ProBioGen to spearhead GMP manufacturing at Berlin’s gene & cell therapy hub
ProBioGen will oversee the design, construction, and operation of the 4,600-square-meter GMP manufacturing unit
ProBioGen will oversee the design, construction, and operation of the 4,600-square-meter GMP manufacturing unit
EU approval makes Novo Nordisk’s oral semaglutide the first and only oral GLP-1 RA to reduce cardiovascular death, heart attack and stroke
AHLL will become a 100% subsidiary of AHEL with 99.42% held by AHEL and balance in the ESOP pool
The portfolio acquired includes Stugeron brand as well as its leading local brands STUGERON FORTE and STUGERON PLUS across 18 markets in the APAC and EMEA regions
New unit boosts innovation in liposomal delivery technologies with 8,500 MT capacity and export-ready production
Combination creates a leading, next generation claims operating system for payers, with end-to-end AI capabilities for claims, payments, care & utilization management, payment integrity, and member engagement, serving 115+ health plans
It will focus on interface between API and formulation manufacturing, reducing carbon footprint in formulation production, creating intellectual property, training next-generation scientists, and setting new industry benchmarks
Subscribe To Our Newsletter & Stay Updated